Literature DB >> 23163235

The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

E Kövari1, F R Herrmann, P R Hof, C Bouras.   

Abstract

AIMS: Cerebral amyloid angiopathy (CAA) represents the deposition of amyloid β protein (Aβ) in the meningeal and intracerebral vessels. It is often observed as an accompanying lesion of Alzheimer's disease (AD) or in the brain of elderly individuals even in the absence of dementia. CAA is largely age-dependent. In subjects with severe CAA a higher frequency of vascular lesions has been reported. The goal of our study was to define the frequency and distribution of CAA in a 1-year autopsy population (91 cases) from the Department of Internal Medicine, Rehabilitation, and Geriatrics, Geneva.
MATERIALS AND METHODS: Five brain regions were examined, including the hippocampus, and the inferior temporal, frontal, parietal and occipital cortex, using an antibody against Aβ, and simultaneously assessing the severity of AD-type pathology with Braak stages for neurofibrillary tangles identified with an anti-tau antibody. In parallel, the relationships of CAA with vascular brain lesions were established.
RESULTS: CAA was present in 53.8% of the studied population, even in cases without AD (50.6%). The strongest correlation was seen between CAA and age, followed by the severity of amyloid plaques deposition. Microinfarcts were more frequent in cases with CAA; however, our results did not confirm a correlation between these parameters.
CONCLUSION: The present data show that CAA plays a role in the development of microvascular lesions in the ageing brain, but cannot be considered as the most important factor in this vascular pathology, suggesting that other mechanisms also contribute importantly to the pathogenesis of microvascular changes.
© 2012 British Neuropathological Society.

Entities:  

Keywords:  Alzheimer's disease; amyloid angiopathy; cortical microinfarcts; immunohistochemistry; neuropathology; vascular

Mesh:

Substances:

Year:  2013        PMID: 23163235      PMCID: PMC3637988          DOI: 10.1111/nan.12003

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  70 in total

1.  Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

Authors:  Roy O Weller; Hong-Yeen Yow; Stephen D Preston; Ingrid Mazanti; James A R Nicoll
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  The significance of cerebrovascular amyloid in the aetiology of superficial (lobar) cerebral haemorrhage and its incidence in the elderly population.

Authors:  T Ishihara; M Takahashi; T Yokota; Y Yamashita; T Gondo; F Uchino; N Iwamoto
Journal:  J Pathol       Date:  1991-11       Impact factor: 7.996

3.  Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia.

Authors:  Mattias Haglund; Ulla Passant; Martin Sjöbeck; Estifanos Ghebremedhin; Elisabet Englund
Journal:  Int J Geriatr Psychiatry       Date:  2006-07       Impact factor: 3.485

4.  Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

Authors:  C L Joachim; J H Morris; D J Selkoe
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

5.  The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study.

Authors:  J De Reuck; V Deramecourt; C Cordonnier; D Leys; C A Maurage; F Pasquier
Journal:  Eur J Neurol       Date:  2011-01-18       Impact factor: 6.089

6.  Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

Authors:  S A Gravina; L Ho; C B Eckman; K E Long; L Otvos; L H Younkin; N Suzuki; S G Younkin
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

7.  Cerebral amyloid angiopathy in dementia and old age.

Authors:  M M Esiri; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

8.  Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-12-04       Impact factor: 17.088

9.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

10.  Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum.

Authors:  K Mak; F Yang; H V Vinters; S A Frautschy; G M Cole
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

View more
  43 in total

1.  Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.

Authors:  Emily L Munger; Melissa K Edler; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2019-01-07       Impact factor: 3.215

2.  The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology.

Authors:  Susanne J van Veluw; Jaco J M Zwanenburg; Annemieke Jm Rozemuller; Peter R Luijten; Wim G M Spliet; Geert Jan Biessels
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

Review 3.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

4.  Focal Solute Trapping and Global Glymphatic Pathway Impairment in a Murine Model of Multiple Microinfarcts.

Authors:  Minghuan Wang; Fengfei Ding; SaiYue Deng; Xuequn Guo; Wei Wang; Jeffrey J Iliff; Maiken Nedergaard
Journal:  J Neurosci       Date:  2017-02-10       Impact factor: 6.167

Review 5.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

6.  Microbleed and microinfarct detection in amyloid angiopathy: a high-resolution MRI-histopathology study.

Authors:  Susanne J van Veluw; Andreas Charidimou; Andre J van der Kouwe; Arne Lauer; Yael D Reijmer; Isabel Costantino; M Edip Gurol; Geert Jan Biessels; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2016-09-19       Impact factor: 13.501

Review 7.  Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.

Authors:  Laura E Jonkman; Boyd Kenkhuis; Jeroen J G Geurts; Wilma D J van de Berg
Journal:  Neurosci Bull       Date:  2019-02-21       Impact factor: 5.203

8.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy.

Authors:  Yael D Reijmer; Panagiotis Fotiadis; Grace A Riley; Li Xiong; Andreas Charidimou; Gregoire Boulouis; Alison M Ayres; Kristin Schwab; Jonathan Rosand; M Edip Gurol; Anand Viswanathan; Steven M Greenberg
Journal:  Stroke       Date:  2016-08-30       Impact factor: 7.914

Review 10.  The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Authors:  Douglas G Peters; James R Connor; Mark D Meadowcroft
Journal:  Neurobiol Dis       Date:  2015-08-22       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.